OPTION AND LICENSE AGREEMENT by and BETWEEN MEDIMMUNE LIMITED and AEVI GENOMIC MEDICINE, INC.Option and License Agreement • November 14th, 2019 • Aevi Genomic Medicine, Inc. • Biological products, (no disgnostic substances) • Delaware
This Option and License Agreement (this “Agreement”) dated the 6th day of August 2019 (the “Agreement Effective Date”) is by and between MedImmune Limited, a company organized under the laws of England and Wales “MedImmune”), and Aevi Genomic Medicine, Inc., a Delaware corporation (“Aevi”). MedImmune and Aevi may each be referred to herein individually as a “Party” and collectively as the “Parties.”
